Other Health

Success Story: Infiniti Research helps an Online Healthcare Provider Increase Profits and Leads with Marketing Service Solutions

Friday, July 3, 2020 - 7:11pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200703005263/en/
    Marketing Service Solutions for an Online Healthcare Provider (Graphic: Business Wire)
    The client is an online healthcare provider based in the US that works to help women with fertility issues.
  • Infinitis research experts prepared a guide with quantitative and qualitative questions to gain insights about marketing initiatives from the top online healthcare providers.
  • Business impact of the marketing service solutions for the online healthcare service provider:
    With the advisory from Infinitis research experts, the company was able to personalize marketing approaches for their patients and drive patient engagement.
  • By leveraging our marketing service engagement, the online healthcare provider was also able to:
    For in-depth guidance and advisory on marketing services solutions and maximizing lead conversions, request more info here.

Intravenous Stopcock Market to Surpass US$ 570.4 Million globally by end of 2027, Says CMI

Friday, July 3, 2020 - 3:08pm

According to Coherent Market Insights, the global intravenous stopcock market is estimated to be valued at US$ 338.6 million in 2020 and is expected to rise at a CAGR of 7.73% during the forecast period (2020-2027).

Key Points: 
  • According to Coherent Market Insights, the global intravenous stopcock market is estimated to be valued at US$ 338.6 million in 2020 and is expected to rise at a CAGR of 7.73% during the forecast period (2020-2027).
  • The global intravenous stopcock market is expected to witness growth, mainly in the emerging economies, owing to product launches and mergers & acquisitions by key players.
  • The Infusions Therapy Standards of Practice recommends replacing stopcock with needle-less connector as soon as the clinical need arises.
  • North America region is projected to be the most lucrative region in the global intravenous stopcock market, owing to the rising prevalence of chronic diseases.

Global Medical Gas Cylinder Market 2020-2024 | Evolving Opportunities with Allied Healthcare Products Inc. and B.N.O.S. Meditech Ltd. | Technavio

Friday, July 3, 2020 - 4:00pm

The global medical gas cylinder market is expected to grow by USD 2 billion during 2020-2024, as per Technavio.

Key Points: 
  • The global medical gas cylinder market is expected to grow by USD 2 billion during 2020-2024, as per Technavio.
  • View the full release here: https://www.businesswire.com/news/home/20200703005183/en/
    Technavio has announced its latest market research report titled Global Medical Gas Cylinder Market 2020-2024 (Graphic: Business Wire)
    Read the 120-page report with TOC on "Medical Gas Cylinder Market Analysis Report by Product (HHH, PBI, and RI), Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024".
  • In addition, the rise in vendors offering customized, innovative products is anticipated to boost the growth of the medical gas cylinder market.
  • Major Five Medical Gas Cylinder Companies:
    Allied Healthcare Products Inc. operates its business through a unified segment.

Global Galactosemia Market Report 2020: Presents Insights Into the Clinical Development Scenario, Growth Prospects and Pipeline Landscape - ResearchAndMarkets.com

Friday, July 3, 2020 - 9:58am

Galactosemia Pipeline Insight, 2020 report outlays comprehensive insights of present clinical development scenario and growth prospects across the Galactosemia market.

Key Points: 
  • Galactosemia Pipeline Insight, 2020 report outlays comprehensive insights of present clinical development scenario and growth prospects across the Galactosemia market.
  • A detailed picture of the Galactosemia pipeline landscape is provided, which includes the disease overview and Galactosemia treatment guidelines.
  • The assessment part of the report embraces in-depth Galactosemia commercial assessment and clinical assessment of the Galactosemia pipeline products from the pre-clinical developmental phase to the marketed phase.
  • Coverage of dormant and discontinued pipeline projects along with the reasons if available across Galactosemia.

KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) - Pipeline Insight, 2020 - ResearchAndMarkets.com

Friday, July 3, 2020 - 9:44am

The "KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • A detailed picture of the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) pipeline landscape is provided, which includes the disease overview and KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) treatment guidelines.
  • The assessment part of the report embraces in-depth KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) commercial assessment and clinical assessment of the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) pipeline products from the pre-clinical developmental phase to the marketed phase.
  • It comprises of detailed profiles of KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) therapeutic products with key coverage of developmental activities, including technology, collaborations, licensing, mergers and acquisition, funding, designations and other product-related details
    Detailed KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) research and development progress and trial details, results wherever available, are also included in the pipeline study.

Complement 3 Glomerulopathy - Global Pipeline Insights Report 2020 - ResearchAndMarkets.com

Friday, July 3, 2020 - 9:39am

Complement 3 Glomerulopathy Pipeline Insight, 2020 report outlays comprehensive insights of present clinical development scenario and growth prospects across the Complement 3 Glomerulopathy market.

Key Points: 
  • Complement 3 Glomerulopathy Pipeline Insight, 2020 report outlays comprehensive insights of present clinical development scenario and growth prospects across the Complement 3 Glomerulopathy market.
  • A detailed picture of the Complement 3 Glomerulopathy pipeline landscape is provided, which includes the disease overview and Complement 3 Glomerulopathy treatment guidelines.
  • The assessment part of the report embraces in-depth Complement 3 Glomerulopathy commercial assessment and clinical assessment of the Complement 3 Glomerulopathy pipeline products from the pre-clinical developmental phase to the marketed phase.
  • Coverage of dormant and discontinued pipeline projects along with the reasons if available across Complement 3 Glomerulopathy.

Schwazze, Formerly Operating as Medicine Man Technologies, Inc., Provides Business Update

Friday, July 3, 2020 - 1:06am

Schwazze, formerly operating as Medicine Man Technologies, Inc. (OTCQX: SHWZ) (Schwazze or the Company"), a leading vertically-integrated Colorado cannabis company, today provided a business update.

Key Points: 
  • Schwazze, formerly operating as Medicine Man Technologies, Inc. (OTCQX: SHWZ) (Schwazze or the Company"), a leading vertically-integrated Colorado cannabis company, today provided a business update.
  • Additionally, since the closing of the acquisition, we have made significant progress in integrating the Mesa Organics and Purplebees operations.
  • The Company remains in negotiations with the following announced acquisition partners, Roots Rx, Medicine Man, MedPharm, Canyon Cultivation, and Medically Correct.
  • Medicine Man Technologies, Inc. is now operating under its new trade name, Schwazze.

InteliChart Partnership with PointClickCare Brings Family Portal to Senior Care Industry

Thursday, July 2, 2020 - 6:29pm

InteliChart, a leader in patient-engagement technology, announced a partnership today with PointClickCare, the leading cloud-based software vendor for the senior care industry.

Key Points: 
  • InteliChart, a leader in patient-engagement technology, announced a partnership today with PointClickCare, the leading cloud-based software vendor for the senior care industry.
  • As a result, senior care providers can now offer residents families and caregivers access to InteliCharts Family Portal.
  • InteliChart is pleased to bring the benefits of our Family Portal to PointClickCares 21,000 skilled nursing facilities, senior living communities, and home health agencies, said InteliChart CEO, Gary Hamilton .
  • With Family Portal, family members and caregivers are empowered to stay informed about the health and well-being of their loved ones in long-term care facilities.

Global Scedosporium Infection Pipeline Insights Report, 2020 - ResearchAndMarkets.com

Thursday, July 2, 2020 - 5:12pm

Scedosporium Infection Pipeline Insight, 2020 report outlays comprehensive insights of present clinical development scenario and growth prospects across the Scedosporium Infection market.

Key Points: 
  • Scedosporium Infection Pipeline Insight, 2020 report outlays comprehensive insights of present clinical development scenario and growth prospects across the Scedosporium Infection market.
  • A detailed picture of the Scedosporium Infection pipeline landscape is provided, which includes the disease overview and Scedosporium Infection treatment guidelines.
  • The assessment part of the report embraces in-depth Scedosporium Infection commercial assessment and clinical assessment of the Scedosporium Infection pipeline products from the pre-clinical developmental phase to the marketed phase.
  • Coverage of dormant and discontinued pipeline projects along with the reasons if available across Scedosporium Infection.

Global Laron Syndrome (LS) Pipeline Landscape Insights Report 2020 - ResearchAndMarkets.com

Thursday, July 2, 2020 - 5:01pm

The "Laron Syndrome (LS) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Laron Syndrome (LS) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report outlays comprehensive insights of present clinical development scenario and growth prospects across the Laron Syndrome (LS) market.
  • A detailed picture of the Laron Syndrome (LS) pipeline landscape is provided, which includes the disease overview and Laron Syndrome (LS) treatment guidelines.
  • The assessment part of the report embraces in-depth Laron Syndrome (LS) commercial assessment and clinical assessment of the Laron Syndrome (LS) pipeline products from the pre-clinical developmental phase to the marketed phase.